Cargando…
Evaluation of the Synergistic Antibacterial Effects of Fosfomycin in Combination with Selected Antibiotics against Carbapenem–Resistant Acinetobacter baumannii
The spread of multi-drug resistant (MDR) pathogens and the lagging pace in the development of novel chemotherapeutic agents warrant the use of combination therapy as a reliable, cost-effective interim option. In this study, the synergistic effects of fosfomycin in combination with other antibiotics...
Autores principales: | Nwabor, Ozioma F., Terbtothakun, Pawarisa, Voravuthikunchai, Supayang P., Chusri, Sarunyou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996625/ https://www.ncbi.nlm.nih.gov/pubmed/33668905 http://dx.doi.org/10.3390/ph14030185 |
Ejemplares similares
-
Synergistic Antibacterial Effects of Meropenem in Combination with Aminoglycosides against Carbapenem-Resistant Escherichia coli Harboring bla(NDM-1) and bla(NDM-5)
por: Terbtothakun, Pawarisa, et al.
Publicado: (2021) -
A Bibliometric Meta-Analysis of Colistin Resistance in Klebsiella pneumoniae
por: Nwabor, Ozioma Forstinus, et al.
Publicado: (2021) -
Synergistic antibacterial effects of colistin in combination with aminoglycoside, carbapenems, cephalosporins, fluoroquinolones, tetracyclines, fosfomycin, and piperacillin on multidrug resistant Klebsiella pneumoniae isolates
por: Ontong, Julalak C., et al.
Publicado: (2021) -
Rifampicin Enhanced Carbapenem Activity with Improved Antibacterial Effects and Eradicates Established Acinetobacter baumannii Biofilms
por: Nwabor, Lois Chinwe, et al.
Publicado: (2023) -
Outcomes of Adjunctive Therapy with Intravenous Cefoperazone-Sulbactam for Ventilator-Associated Pneumonia Due to Carbapenem-Resistant Acinetobacter baumannii
por: Kanchanasuwan, Siripen, et al.
Publicado: (2021)